🇨🇿 Ústav pro státní kontrolu veterinárních biopreparátů a léčiv PL
Pharma & cosmeticsFood & beveragesMicrobiology
Ústav pro státní kontrolu veterinárních biopreparátů a léčiv is a laboratory accredited by ČIA under number 1219 (Brno, Czech Republic). Its accreditation scope covers 76 test methods in the following areas: Pharma & cosmetics, Food & beverages, Microbiology. Test objects include: Medicinal products, Medicinal products, biological materials, Medicinal products - veterinary immunological medicinal products, Urine, muscle.
At a glance
- Accreditation number: ČIA 1219
- Methods in scope: 76
- Types of test objects: 38
- City: Brno, Czech Republic
- Valid until: 14-09-2027
- Accreditation number
- 1219
- Accreditation body
- ČIA
- Address
- Hudcova 232/56a, Medlánky, 621 00 Brno
- City
- Brno, Czech Republic
- Division
- Laboratorium Badawcze
- Valid until
- 14-09-2027
What this laboratory tests (38)
- Medicinal products — 24 methods
- Medicinal products, biological materials — 6 methods
- Medicinal products - veterinary immunological medicinal products — 4 methods
- Urine, muscle — 4 methods
- Urine — 3 methods
- Active pharmaceutical ingredients, medicinal products — 2 methods
- Oils — 2 methods
- Active pharmaceutical ingredients, medicinal products, medicated feeding stuffs — 1 method
- Animal tissue — 1 method
- Blood plasma — 1 method
- Blood plasma, eggs, muscle, honey, feathers, milk, feedstuffs, feed water, egg shells — 1 method
- Blood plasma, hair — 1 method
- Blood plasma, milk — 1 method
- Diagnostic preparations, biological material — 1 method
- Feathers — 1 method
- and 23 more
Laboratory sections (2)
- Official Medicine Control Laboratory — 46 methods
- Laboratory for Monitoring of Residues of Extraneous Substances — 30 methods
Laboratory locations
- Urzędowe Laboratorium Kontroli Weterynaryjnych Produktów Leczniczych — Hudcova 232/56a
- Laboratorium Monitorowania Pozostałości Substancji Obcych — Palackého 1309/174
Certificate information
- Certificate date
- 02.07.2026
Accreditation scope — test methods (76)
| No. | Test object | Methodology / Parameters | Technique | Reference document | |
|---|---|---|---|---|---|
| Official Medicine Control Laboratory | |||||
| 1 | Medicinal products | Microbiological determination of the efficiency of antimicrobial agents by diffusion plate method Bacitracin Zn dihydrostreptomycin sulfate erytromycin gentamicin sulfate kanamycin monosulfate neomycin sulfate nystatin rifamycin sodium spiramycin streptomycin sulfate tylosin tylosin tartrate Regulated area: Tests |
SOP 01 (Ph.Eur. 2.7.2) | ||
| 2 | Medicinal products | Sterility test Regulated area: Tests |
SOP 04 (Ph.Eur. 2.6.1) | ||
| 3 | Medicinal products | Microbiological testing of non-sterile products - Enumeration of total viable microorganisms and detection of specified microorganisms Regulated area: Tests |
SOP 05 (Ph.Eur. 2.6.12; Ph.Eur. 2.6.13) | ||
| 4 | Medicinal products | Determination of sensitivity to antimicrobial agents by disk diffusion method Regulated area: Tests |
SOP 06 (Standardy EUCAST, CLSI) | ||
| 5 | Medicinal products | Determination of sensitivity to antimicrobial agents by microdilution method – MIC test Regulated area: Tests |
SOP 07 (Standardy EUCAST, CLSI) | ||
| 6 | Medicinal products | Determination of sensitivity to antimicrobial agents by E-test Regulated area: Tests |
SOP 08 (Standardy EUCAST, CLSI) | ||
| 7 | Medicinal products, biological materials | Detection of mycoplasma by culture method Regulated area: Tests |
SOP 11 (Ph.Eur. 2.6.7) | ||
| 8 | Medicinal products | Test for bacterial endotoxins by LAL test Regulated area: Tests |
SOP 14 (Ph.Eur. 2.6.14) | ||
| 9 | Medicinal products | Test of the efficiency of antimicrobial preservation Regulated area: Tests |
SOP 57 (Ph.Eur. 5.1.3) | ||
| 10 | Medicinal products | Enumeration of declared living bacteria or fungi by culture method Regulated area: Tests |
SOP 70 (Ph.Eur. Mon. 0062) | ||
| 11 | Medicinal products | Detection of bacterial and fungal contamination by culture method Regulated area: Tests |
SOP 71 (Ph.Eur. 2.6.1) | ||
| 12 | Medicinal products | Enumeration of hyphae by microscopic method Regulated area: Tests |
SOP 96 (Registrační dokumentace výrobce veterinárního léčivého přípravku) | ||
| 13 | Medicinal products | Bacteriological identification by culture, microscopic method and biochemical tests Regulated area: Tests |
SOP 97 (Clinical Veterinary Microbiology, 1994; Color Atlas and Textbook of Diagnostic Microbiology, 2006; Obecná bakteriologie, 1981) | ||
| 14 | Veterinary preparations, medicinal products | Enumeration of probiotic bacteria strains Regulated area: Tests |
SOP 113 (ČSN EN 15788 (467049); ČSN EN 15787 (467048); ČSN 560094) | ||
| 15 | Medicinal products | Determination of the efficiency of inactivated vaccines against equine influenza in guinea pigs by Hemagglutination Inhibition Test (HIT) Regulated area: Tests |
SOP 55 (Ph.Eur. Mon. 0249; Manual OIE CH.2.5.7) | ||
| 16 | Medicinal products, biological materials | Detection of Mycoplasma species by PCR method Regulated area: Tests |
SOP 65 (Ph.Eur. 2.6.7) | ||
| 17 | Medicinal products | Determination of the efficiency of inactivated erysipelas vaccines in mice by ELISA method Regulated area: Tests |
SOP 75 (Ph.Eur. 5.2.1; Ph. Eur. Mon. 0064) | ||
| 18 | Medicinal products | Determination of rabies virus titer by microtitration method Regulated area: Tests |
SOP 76 (Ph.Eur. Mon. 0746) | ||
| 19 | Medicinal products | Determination of myxomatosis virus titer by microtitration method Regulated area: Tests |
SOP 78 (Ph.Eur. Mon. 1943) | ||
| 20 | Medicinal products | Determination of the efficiency of inactivated rabies vaccine by NIH test Regulated area: Tests |
SOP 79 (Ph.Eur. Mon. 0451) | ||
| 21 | Medicinal products | Determination of the efficiency of inactivated vaccines against Newcastle disease in the vaccine by ELISA method Regulated area: Tests |
SOP 86 (Ph.Eur. Mon. 0870) | ||
| 22 | Medicinal products | Determination of the efficiency of inactivated rabies vaccine by serological method with immunofluorescence detection Regulated area: Tests |
SOP 90 (Ph.Eur. Mon. 0451) | ||
| 23 | Medicinal products | Determination of Newcastle disease virus titer in chicken embryos by hemagglutination test Regulated area: Tests |
SOP 92 (Ph.Eur. Mon. 0450) | ||
| 24 | Medicinal products, biological materials | Detection of RNA viruses by RT qPCR method Infectious bursal disease virus (IBDV) reticuloendotheliosis virus (REV) pestiviruses infectious bronchitis virus (IBV) avian leukosis virus (ALV) Schmallenberg virus (SBV) Regulated area: Tests |
SOP 93 (Ph.Eur. 2.6.21) | ||
| 25 | Medicinal products | Detection of Infectious bursal disease virus titer in CEF Regulated area: Tests |
SOP 95 (Ph.Eur. Mon. 0587) | ||
| 26 | Medicinal products, biological materials | Detection of DNA viruses by qPCR method Chicken anaemia virus (CAV) Marek's disease virus (MDV-1) Regulated area: Tests |
SOP 99 (Ph.Eur. 2.6.21) | ||
| 27 | Medicinal products, biological materials | Detection of DNA viruses by PCR method Infectious laryngotracheitis virus (ILTV) infectious bovine rhinotracheitis virus (IBRV) fowl adenovirus (FAdV) Torque teno sus virus (TTSuV) canine adenovirus 2 (CAV-2) Regulated area: Tests |
SOP 100 (Ph.Eur.2.6.21) | ||
| 28 | Medicinal products, biological materials | Detection of RNA viruses by RT PCR method Newcastle disease virus (NDV) pestiviruses bovine parainfluenza virus type 3 (BPIV-3) avian encephalomyelitis virus (AEV) avian orthoreovirus (ARV) porcine reproductive and respiratory syndrome virus (PRRSV) turkey rhinotracheitis virus (TRTV) bovine enterovirus (BEV) Regulated area: Tests |
SOP 101 (Ph.Eur. 2.6.21) | ||
| 29 | Diagnostic preparations, biological material | Test of the efficiency of avian or bovine tuberculin in guinea pigs Regulated area: Tests |
SOP 112 (Ph.Eur. Mon. 0536) | ||
| 30 | Medicinal products | Determination of glycoprotein in inactivated rabies vaccines by ELISA method Regulated area: Tests |
SOP 121 (Ph. Eur. Mon. 0451) | ||
| 31 | Medicinal products | Determination of infectious bovine rhinotracheitis (IBR) virus by microtitration method Regulated area: Tests |
SOP 122 (Ph. Eur. Mon. 0696) | ||
| 32 | Medicinal products | Determination of the efficiency of inactivated vaccines against infectious bovine rhinotracheitis (IBR) in guinea pigs by ELISA method Regulated area: Tests |
SOP 123 (Ph. Eur. Mon. 2674) | ||
| 33 | Solutions | Determination of pH by potentiometry Regulated area: Tests |
SOP 37 (Ph.Eur. 2.2.3) | ||
| 34 | Medicinal products - veterinary immunological medicinal products | Determination of phenol by spectrophotometry Regulated area: Tests |
SOP 38 (Ph.Eur. 2.5.15; Ph.Eur. 2.2.25) | ||
| 35 | Medicinal products - veterinary immunological medicinal products | Determination of free formaldehyde by spectrophotometry Regulated area: Tests |
SOP 39 (Ph.Eur. 2.4.18; Ph.Eur. 2.2.25) | ||
| 36 | Medicinal products - veterinary immunological medicinal products | Determination of aluminium by chelatometry Regulated area: Tests |
SOP 40 (Ph.Eur. 2.5.13) | ||
| 37 | Medicinal products - veterinary immunological medicinal products | Determination of thiomersal by spectrophotometry Regulated area: Tests |
SOP 41 (Ph.Eur. 2.2.25) | ||
| 38 | Liquid samples | Determination of density with density meter with an oscillating tube Regulated area: Tests |
SOP 42 (Ph.Eur. 2.2.5) | ||
| 39 | Liquid and solid samples | Determination of water content by Karl Fischer method Regulated area: Tests |
SOP 44 (Ph.Eur. 2.5.12) | ||
| 40 | Feeding stuffs, medicated feeding stuffs | Determination of sulphonamides by LC-DAD method Sulfadimidine sulfadiazine sulfamethoxazole sulfamerazine Regulated area: Tests |
SOP 50 (Ph.Eur. 2.2.29; Ph.Eur. 2.2.46) | ||
| 41 | Medicinal products, feeding stuffs, medicated feeding stuffs | Determination of tetracyclines by LC-DAD method Tetracycline oxytetracycline doxycycline chlorotetracycline 4-epichlorotetracycline and their salts Regulated area: Tests |
SOP 62 (Ph.Eur. 2.2.29; Ph.Eur. 2.2.46) | ||
| 42 | Active pharmaceutical ingredients, medicinal products | Clarity and degree of opalescence of liquids - visually Regulated area: Tests |
SOP 104A (Ph.Eur. 2.2.1) | ||
| 43 | Active pharmaceutical ingredients, medicinal products | Degree of coloration of liquids - visually Regulated area: Tests |
SOP 104B (Ph.Eur. 2.2.2) | ||
| 44 | Active pharmaceutical ingredients, medicinal products, medicated feeding stuffs | Identification and determination of the content of active substances, excipients and impurities by LC-DAD method Altrenogest amoxicillin ampicillin amprolium hydrochloride benzylpenicillin cefalexin ceftiofur detomidine hydrochloride dexamethasone dexamethasone acetate dexamethasone phosphate Na dihydrostreptomycin enrofloxacin febantel phenol fipronil florfenicol flubendazole flunixin hyoscin butylbromide chlorphenamine maleate imidacloprid ivermectin clindamycin cloxacillin clavulanic acid sorbic acid linkomycin hydrochloride methoprene methylparaben metronidazole milbemycin oxime moxidectin nandrolone laurate permethrin pimobendan polymyxin sulfate praziquantel prednisolone procaine propylparaben pyrantel embonate pyriproxyfen sulfadoxine tiabendazole tilmicosin trimethoprim Regulated area: Tests |
SOP 105 (Ph.Eur. 2.2.29; Ph.Eur.2.2.46) | ||
| 45 | Solid samples | Determination of loss on drying in an oven Regulated area: Tests |
SOP 118 (Ph.Eur. 2.2.32) | ||
| 46 | Oils | Determination of cannabidiol (CBD) by LC-DAD method Regulated area: Tests |
SOP 119 (Ph.Eur. 2.2.29; Ph.Eur. 2.2.46) | ||
| Laboratory for Monitoring of Residues of Extraneous Substances | |||||
| 47 | Renal fat, muscle | Determination of synthetic gestagens by GC/MS method Medroxyprogesterone acetate acetoxyprogesterone megestrol acetate melengestrol acetate chlormadinone acetate altrenogest delmadinone acetate Regulated area: Tests |
SOP 23 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 48 | Muscle, eggs, milk, honey, urine, feedstuffs, liver, egg shells, feathers, hair | Determination of chloramphenicol by GC/MS-NCI method Regulated area: Tests |
SOP 24 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 49 | Urine, muscle | Determination of nortestosterone by GC/MS method Regulated area: Tests |
SOP 25 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 50 | Blood plasma | Determination of testosterone by GC/MS method Regulated area: Tests |
SOP 27A (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 51 | Urine | Determination of androgenic steroids by GC/MS method Testosterone nortestosterone methyltestosterone boldenone methylboldenone chlortestosterone norclostebol chlorandrostendione (CLAD) Regulated area: Tests |
SOP 27B (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 52 | Urine, muscle, liver | Determination of trenbolone by GC/MS method Regulated area: Tests |
SOP 28 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 53 | Urine, muscle | Determination of resorcylic acid lactones (RALs) by GC/MS method Zeranol taleranol zearalanon zearalenon α-zearalenol β-zearalenol Regulated area: Tests |
SOP 29 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 54 | Blood plasma, milk | Determination of estradiol by GC/MS method Regulated area: Tests |
SOP 52 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 55 | Blood plasma, hair | Determination of estradiol esters by GC/MS method Estradiol acetate estradiol benzoate estradiol cypionate estradiol enanthate estradiol valerate Regulated area: Tests |
SOP 127 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 56 | Urine, muscle | Determination of ethinylestradiol and estradiol by GC/MS method Regulated area: Tests |
SOP 53 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 57 | Muscle, urine, liver | Determination of steroids by GC/MS method Nortestosterone methyltestosterone boldenone methylboldenone chlortestosterone norclostebol chlorandrostendione (CLAD) ethinylestradiol Regulated area: Tests |
SOP 54 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 58 | Urine, muscle, liver, milk, feedstuffs | Determination of stilbenes by GC/MS method Diethystilbestrol dienestrol benzoestrol hexestrol Regulated area: Tests |
SOP 85 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 59 | Urine, liver | Screening determination of resorcylic acid lactones (RALs) by GC/MS method Zeranol taleranol zearalanon zearalenon α-zearalenol β-zearalenol Regulated area: Tests |
SOP 94 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 60 | Muscle, urine, milk, blood plasma, eggs | Determination of chloramphenicol by LC-MS/MS method Regulated area: Tests |
SOP 88 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 61 | Renal fat, food supplements | Determination of gestagens by LC-MS/MS method Medroxyprogesterone acetate acetoxyprogesterone megestrol acetate melengestrol acetate chlormadinone acetate altrenogest progesterone delmadinone acetate flugestone acetate Regulated area: Tests |
SOP 91 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 62 | Kidney, muscle | Determination of sedatives by LC-MS/MS method Acepromazine propionylpromazine chloropromazine azaperone azaperol carazolol haloperidol haloperidol metabolite xylazine Regulated area: Tests |
SOP 80 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 63 | Urine, milk, feedstuffs, liver, hair, lungs | Determination of β-agonists by LC-MS/MS method Brombuterol cimaterol cimbuterol clenbuterol isoxsuprin mabuterol mapenterol ractopamine ritodrine salbutamol terbutaline tulobuterol zilpaterol chlorbrombuterol hydroxymethylclenbuterol clenpenterol clenproperol salmeterol fenoterol orciprenalin carbuterol pirbuterol sotalol clencyclohexerol formoterol clenisopenterol labetalol clenhexerol Regulated area: Tests |
SOP 82 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 64 | Urine, muscle | Determination of stanozolol and 16-β-hydroxystanozolol by LC-MS/MS method Regulated area: Tests |
SOP 77 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 65 | Blood plasma, eggs, muscle, honey, feathers, milk, feedstuffs, feed water, egg shells | Determination of nitroimidazoles by LC-MS/MS method Dimetridazole ronidazole metronidazole metronidazole-OH 2-hydroxymethyl-1-methyl-5-nitroimidazole (HMMNI) carnidazole ipronidazole ipronidazole-OH ternidazole secnidazole tinidazole ornidazole Regulated area: Tests |
SOP 81 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 66 | Muscle, milk, honey | Determination of dapsone by LC-MS/MS method Regulated area: Tests |
SOP 84 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 67 | Muscle, milk, honey, eggs | Determination of nitrofurans by LC-MS/MS method 3-amino-2-oxazolidinone (AOZ) 5-methylmorfolino-3-amino-2-oxazolidinone (AMOZ) 1-amino-hydantoin hydrochloride (AHD) semicarbazide (SEM) 3,5-dinitrosalicylic acid hydrazide (DNSH) Regulated area: Tests |
SOP 72 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 68 | Urine, muscle, milk | Determination of thyreostatics by LC-MS/MS method 5-methylthiouracil 6-methylthiouracil propylthiouracil thiouracil tapazole benzylthiouracil mercaptobenzimidazole phenylthiouracil Regulated area: Tests |
SOP 73 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 69 | Urine, animal tissue | Determination of corticosteroids by LC-MS/MS method Dexamethasone triamcinolone betamethasone fluocinolone fluoromethoIone beclomethasone flumethasone prednisone methylprednisolone prednisolone Regulated area: Tests |
SOP 74 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 70 | Hair, blood plasma | Determination of steroid esters by LC-MS/MS method Estradiol benzoate testosterone propionate testosterone benzoate testosterone isocapronate testosterone decanoate testosterone enanthate testosterone phenylpropionate testosterone cypionate nortestosterone propionate nortestosterone benzoate nortestosterone phenylpropionate nortestosterone cypionate nortestosterone decanoate Regulated area: Tests |
SOP 98 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 71 | Honey | Determination of rotenone by LC-MS/MS method Regulated area: Tests |
SOP 114 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 72 | Oils | Determination of tetrahydrocannabinol (THC) by LC-MS/MS method Regulated area: Tests |
SOP 115 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 73 | Urine | Determination of selective androgen receptor modulators (SARMs) by LC-MS/MS method Andarine ostarine bicalutamide Regulated area: Tests |
SOP 120 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 74 | Urine | Determination of 19-noretiocholanolone glucuronide and 19-norandrosterone glucuronide by LC-MS/MS method Regulated area: Tests |
SOP 124 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 75 | Feathers | Determination of antimicrobial substances by LC-MS/MS method Amoxicillin ciprofloxacin enrofloxacin doxycycline phenoxymethylpenicillin lincomycin neomycin spectinomycin sulfamethoxazole tiamulin trimetoprim Regulated area: Tests |
SOP 125 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
| 76 | Animal tissue | Determination of antivirals by LC-MS/MS method Acyclovir amantadine arbidol arbidol sulfone efavirenz ganciclovir imiquimod laninamivir lopinavir memantine moroxydine nevirapine oseltamivir oseltamivir acid penciclovir peramivir ribavirin rimantadine saquinavir viramidine zanamivir Regulated area: Tests |
SOP 126 (Nařízení Komise (EU) 2021/808, čl. 3) | ||
Reference standards (122)
Clinical Veterinary Microbiology, 1994
Color Atlas and Textbook of Diagnostic Microbiology, 2006
Manual OIE CH.2.5.7
Nařízení Komise (EU) 2021/808, čl. 3
Obecná bakteriologie, 1981
Ph. Eur. Mon. 0064
Ph. Eur. Mon. 0451
Ph. Eur. Mon. 0696
Ph. Eur. Mon. 2674
Ph.Eur. 2.2.1
Ph.Eur. 2.2.2
Ph.Eur. 2.2.25
Ph.Eur. 2.2.29
Ph.Eur. 2.2.3
Ph.Eur. 2.2.32
Ph.Eur. 2.2.46
Ph.Eur. 2.2.5
Ph.Eur. 2.4.18
Ph.Eur. 2.5.12
Ph.Eur. 2.5.13
Ph.Eur. 2.5.15
Ph.Eur. 2.6.1
Ph.Eur. 2.6.12
Ph.Eur. 2.6.13
Ph.Eur. 2.6.14
Ph.Eur. 2.6.21
Ph.Eur. 2.6.7
Ph.Eur. 2.7.2
Ph.Eur. 5.1.3
Ph.Eur. 5.2.1
Ph.Eur. Mon. 0062
Ph.Eur. Mon. 0249
Ph.Eur. Mon. 0450
Ph.Eur. Mon. 0451
Ph.Eur. Mon. 0536
Ph.Eur. Mon. 0587
Ph.Eur. Mon. 0746
Ph.Eur. Mon. 0870
Ph.Eur. Mon. 1943
Ph.Eur.2.2.46
Ph.Eur.2.6.21
Registrační dokumentace výrobce veterinárního léčivého přípravku
SOP 01
SOP 04
SOP 05
SOP 06
SOP 07
SOP 08
SOP 100
SOP 101
SOP 104A
SOP 104B
SOP 105
SOP 11
SOP 112
SOP 113
SOP 114
SOP 115
SOP 118
SOP 119
SOP 120
SOP 121
SOP 122
SOP 123
SOP 124
SOP 125
SOP 126
SOP 127
SOP 14
SOP 23
SOP 24
SOP 25
SOP 27A
SOP 27B
SOP 28
SOP 29
SOP 37
SOP 38
SOP 39
SOP 40
SOP 41
SOP 42
SOP 44
SOP 50
SOP 52
SOP 53
SOP 54
SOP 55
SOP 57
SOP 62
SOP 65
SOP 70
SOP 71
SOP 72
SOP 73
SOP 74
SOP 75
SOP 76
SOP 77
SOP 78
SOP 79
SOP 80
SOP 81
SOP 82
SOP 84
SOP 85
SOP 86
SOP 88
SOP 90
SOP 91
SOP 92
SOP 93
SOP 94
SOP 95
SOP 96
SOP 97
SOP 98
SOP 99
Standardy EUCAST, CLSI
ČSN 560094
ČSN EN 15787 (467048)
ČSN EN 15788 (467049)